| Date Filed | Type | Description |
| 06/02/2023 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.|
Txns:
| Sold 2,485,923 shares
@ $1.58, valued at
$3.9M
Sold 955,738 shares
@ $1.58, valued at
$1.5M
|
|
| 06/02/2023 |
SC 13D/A
| Apeiron Investment Group Ltd. reports a 0% stake in Sensei Biotherapeutics, Inc. |
| 05/23/2023 |
SC 13D/A
| Apeiron Investment Group Ltd. reports a 11.1% stake in Sensei Biotherapeutics, Inc. |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
SC 13D/A
| Apeiron Investment Group Ltd. reports a 11.2% stake in Sensei Biotherapeutics, Inc. |
| 02/27/2023 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on Sensei Biotherapeutics, Inc.|
Txns:
| Bought 1,100 shares
@ $1.615, valued at
$1.8k
Bought 1,100 shares
@ $1.6023, valued at
$1.8k
|
|
| 02/10/2023 |
SC 13G/A
| Apeiron Investment Group Ltd. reports a 19.4% stake in ATAI Life Sciences N.V. |
| 11/21/2022 |
SC 13D/A
| Apeiron Investment Group Ltd. reports a 11.2% stake in Sensei Biotherapeutics, Inc. |
| 07/20/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/19/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/03/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 67,703 shares
@ $5.0886, valued at
$344.5k
Bought 68,688 shares
@ $4.9505, valued at
$340k
|
|
| 05/02/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 34,700 shares
@ $4.4579, valued at
$154.7k
Bought 21,900 shares
@ $4.4658, valued at
$97.8k
|
|
| 04/26/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 52,820 shares
@ $4.827, valued at
$255k
Bought 8,961 shares
@ $4.781, valued at
$42.8k
|
|
| 04/20/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 54,322 shares
@ $5.1113, valued at
$277.7k
Bought 65,315 shares
@ $5.125, valued at
$334.7k
|
|
| 04/18/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 4,967 shares
@ $5.19, valued at
$25.8k
|
|
| 04/14/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 55,197 shares
@ $4.8836, valued at
$269.6k
|
|
| 04/12/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 57,689 shares
@ $4.8127, valued at
$277.6k
Bought 53,926 shares
@ $4.8317, valued at
$260.6k
|
|
| 04/07/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 1,000,000 options to buy
@ $10.103, valued at
$10.1M
|
|
| 02/10/2022 |
SC 13G/A
| Apeiron Investment Group Ltd. reports a 10.6% stake in Sensei Biotherapeutics, Inc. |
| 02/10/2022 |
SC 13G
| Apeiron Investment Group Ltd. reports a 19.7% stake in ATAI Life Sciences N.V. |
| 12/30/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/25/2021 |
3/A
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 3/A on ATAI Life Sciences N.V. |
| 06/24/2021 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 700,000 shares
@ $15, valued at
$10.5M
|
|
| 06/17/2021 |
3
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 3 on ATAI Life Sciences B.V. |
| 02/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |